Six experts resign from Trump HIV/AIDS panel

June 19, 2017

Six top health advisors have resigned from Donald Trump's advisory council on HIV/AIDS, complaining that the US president doesn't really care about combatting the illness.

In a letter published Friday in Newsweek, Scott Schoettes said the Trump administration has "no strategy" on AIDS and that he and his five colleagues will be more effective advocating for change from the outside.

Schoettes, counsel and HIV project director at Lambda Legal, resigned Tuesday from the Presidential Advisory Council on HIV/AIDS, along with Lucy Bradley-Springer, Gina Brown, Ulysses Burley III, Michelle Ogle and Grissel Granados.

The council can have up to 25 members.

"The Trump administration has no strategy to address the on-going HIV/AIDS epidemic, seeks zero input from experts to formulate HIV policy, and—most concerning—pushes legislation that will harm people living with HIV and halt or reverse important gains made in the fight against this disease," Schoettes wrote.

"If we do not ensure that US leadership at the executive and legislative levels are informed by experience and expertise, real people will be hurt and some will even die," he said.

"Because we do not believe the Trump administration is listening to—or cares—about the communities we serve as members of PACHA, we have decided it is time to step down."

PACHA, which was created in 1995, includes , researchers, , faith leavers, HIV advocates and people living with HIV. Its helps inform the National HIV/AIDS Strategy, which was last revised in 2015.

Schoettes noted that Trump failed to appoint a head of the White House Office of National AIDS Policy, a senior advisory position, and took down the Office of National AIDS Policy website the very day he took office—on January 20—and has yet to replace it.

He also stressed that changes Trump and his fellow Republicans in Congress are seeking to the sweeping care reform initiated by former president Barack Obama would be "extremely harmful" to people living with HIV or AIDS.

Schoettes cited data showing that only 40 percent of people living with HIV in the United States can access life-saving medications.

Explore further: National Archives to White House: Save all Trump tweets

Related Stories

National Archives to White House: Save all Trump tweets

April 3, 2017
The National Archives and Records Administration has told the White House to keep each of President Donald Trump's tweets, even those he deletes or corrects, and the White House has agreed.

Trump signs NASA bill, ponders sending Congress to space (Update 3)

March 21, 2017
President Donald Trump signed legislation Tuesday adding human exploration of Mars to NASA's mission. Could sending Congress into space be next?

The health consequences of Trump's global gag order

May 19, 2017
President Donald Trump recently signed an executive order that media reports say could obstruct nearly US$8.8 billion the U.S. spends annually to fight deadly diseases abroad. Here, Maureen Miller, a Columbia University Medical ...

Trump doesn't rule out 'amended' Obamacare: WSJ

November 11, 2016
US President-elect Donald Trump has said he will consider an "amended" version of Barack Obama's signature health care law—a sign of a shift in position after repeatedly vowing on the campaign trail that he would repeal ...

Recommended for you

Details of HIV-1 structure open door for potential therapies

August 9, 2018
New research provides details of how the structure of the HIV-1 virus is assembled, findings that offer potential new targets for treatment.

Researchers uncover potential new drug targets in the fight against HIV

August 7, 2018
Johns Hopkins scientists report they have identified two potential new drug targets for the treatment of HIV. The finding is from results of a small, preliminary study of 19 people infected with both HIV—the virus that ...

Naltrexone helps HIV positive individuals reduce heavy alcohol use

August 7, 2018
Extended-release naltrexone—an injection that decreases heavy drinking in the general population when taken in conjunction with counseling—appears to help HIV-positive individuals reduce their number of heavy drinking ...

EU door opens for generic version of AIDS medicine Truvada

July 26, 2018
Patient associations on Thursday lauded an EU decision to allow the sale of generic versions of Truvada, an anti-retroviral medicine used by those diagnosed HIV-positive, the virus causing AIDS.

First randomised trial of 'kick and kill' approach to HIV cure leaves puzzles to be solved

July 24, 2018
Researchers have reported the results of the first randomised clinical trial to test a novel strategy involving waking up and then killing the 'sleeping' HIV that is hiding in the body using an experimental approach known ...

Scientists report setbacks in quest for AIDS cure

July 24, 2018
Scientists reported setbacks Tuesday in the quest for an AIDS cure, and highlighted concerns about inconclusive evidence linking a promising new HIV drug to birth defects.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.